Herein, we found that individuals with both precursors (i.e., MBL and CHIP-CLL) have a 19% (~1 in 5) chance of developing lymphoid malignancy in 10 years relative to just 1% (~1 in 110) in those individuals without these precursors. This evidence concerns the gene STUB1 and B-cell chronic lymphocytic leukemia.